Prevention of Cardiovascular Disease The effect of atorvastatin on fatal and non-fatal coronary heart disease was assessed in a randomised, double-blind, placebo-controlled study, the Anglo-Scandinavian Cardiac Outcomes Trial Lipid Lowering Arm (ASCOT-LLA).
Kardiovaskulaarse haiguse ennetamine Atorvastatiini toimet fataalsele ja mittefataalsele südamepärgarteritõvele hinnati randomiseeritud topeltpimeda menetlusega platseeboga kontrollitud uuringus the Anglo - Scandinavian Cardiac Outcomes Trial Lipid Lowering Arm (ASCOT- LLA).